Definition and Discovery of Tandem SH3-Binding Motifs Interacting with Members of the p47phox-Related Protein Family
Biomolecules · 2025
DOI: 10.3390/biom15121641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Zsofia E Kalman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, 1088 Budapest, Hungary. Hauptthemen laut MEDLINE: src Homology Domains, NADPH Oxidases. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Fund of the Ministry of Culture and Innovation, János Bolyai Research Fellowship of the Hungarian Academy of Sciences, Flanders Innovation & Entrepreneurship Agency.
Abstract (Originalsprache)
SH3 domains are widespread protein modules that mostly bind to proline-rich short linear motifs (SLiMs). Most known SH3 domain-motif interactions and canonical or non-canonical recognition specificities are described for individual SH3 domains. Although cooperation and coordinated motif binding between tandem SH3 domains has already been described for members of the p47phox-related protein family, individual cases have never been collected and analyzed collectively, which precluded the definition of the binding preferences and targeted discovery of further instances. Here, we apply an integrative approach that includes data collection, curation, bioinformatics analyses and state-of-the-art structure prediction methods to fill these gaps. A search of the human proteome with the sequence signatures of SH3 tandemization and follow-up structure analyses suggest that SH3 tandemization could be specific for this family. We define the optimal binding preference of tandemly arranged SH3 domains as [PAVIL]PPR[PR][^DE][^DE] and propose potential new instances of this SLiM among the family members and their binding partners. Structure predictions suggest the possibility of a novel, reverse binding mode for certain motif instances. In all, our comprehensive analysis of this unique SH3 binding mode enabled the identification of novel, interesting tandem SH3-binding motif candidates with potential therapeutic relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, 1088 Budapest, Hungary.
- Structural Biology Brussels (SBB), Department of Bioengineering Sciences, Vrije Universiteit Brussel (VUB), 1050 Brussels, Belgium.
- VIB-VUB Center for Structural Biology, Vlaams Instituut voor Biotechnologie (VIB), 1050 Brussels, Belgium.
- Department of Bioinformatics, Semmelweis University, Tűzoltó u. 7, 1094 Budapest, Hungary.
- Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, 1117 Budapest, Hungary.
ORCID-Profile: Zsofia E Kalman, Tamas Lazar, Laszlo Dobson, Rita Pancsa
Förderung
- National Research, Development and Innovation Fund of the Ministry of Culture and Innovation
- János Bolyai Research Fellowship of the Hungarian Academy of Sciences
- Flanders Innovation & Entrepreneurship Agency
- University Research Scholarship Programme 2024
- FEBS ST Fellowship 2025
- HUN-REN Research Centre for Natural Sciences
Zitieren
APA
Kalman, Z. E., Lazar, T., Dobson, L., & Pancsa, R. (2025). Definition and Discovery of Tandem SH3-Binding Motifs Interacting with Members of the p47phox-Related Protein Family. Biomolecules. https://doi.org/10.3390/biom15121641
Vancouver
Kalman ZE, Lazar T, Dobson L, Pancsa R. Definition and Discovery of Tandem SH3-Binding Motifs Interacting with Members of the p47phox-Related Protein Family. Biomolecules. 2025. doi:10.3390/biom15121641
BibTeX
@article{Kalman2025,
author = {Kalman, Zsofia E and Lazar, Tamas and Dobson, Laszlo and Pancsa, Rita},
title = {Definition and Discovery of Tandem SH3-Binding Motifs Interacting with Members of the p47phox-Related Protein Family},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15121641}
}
EUVIMED